Clinical Trial Update: A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ataciguat (HMR1766) for effects on aortic valve calcification in patients with aortic valve stenosis; trial completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Ataciguat (Ataciguat)

Snippet

Sponsor: Mayo Clinic | Conditions: Aortic Valve Stenosis | Phase 2 | Status: COMPLETED | Results posted: 2020-01-18